21 results
Environment
PROJECT NUMBER • 2013-027
PROJECT STATUS:
COMPLETED

ASBTIA: Optimising the use of praziquantel to manage blood fluke infections in commercially ranched SBT

This report provides a summary of work performed to develop methods to quantify Cardicola forsteri and Cardicola orientalis infections in Southern Bluefin Tuna (SBT) and an in vitro study to determine the efficacy of praziquantel as a treatment for C. forsteri infections. The project was also...
ORGANISATION:
SARDI Food Safety and Innovation
Industry
Industry
PROJECT NUMBER • 2017-020
PROJECT STATUS:
COMPLETED

Identification of muscle parasite in Yellowtail Kingfish (Seriola lalandi) and Mahi Mahi (Coryphaena hippurus), and determination as to the efficacy of non-invasive screening technology for the purpose of identifying infected fish in a commercial fish processing environment

Yellowtail kingfish (Seriola lalandi) and Mahi mahi (Coryphaena hippurus) are actively targeted by fishers in the warmer waters of northern NSW. Both species are becoming increasingly important to local fishers with escalating demand due to increased consumer awareness of the premium eating quality...
ORGANISATION:
Department of Primary Industries (QLD)
Environment
PROJECT NUMBER • 2003-220
PROJECT STATUS:
COMPLETED

Innovative Solutions for Aquaculture: potential for parasite interactions between wild and farmed kingfish, discrimination of farmed and wild fish and assessment of migratory behaviour

This project greatly contributed to an increased understanding of parasite fauna of yellowtail kingfish in Australian waters. This baseline information is critical to understanding potential parasite interactions between wild and farmed kingfish. Our risk assessment enables consideration...
ORGANISATION:
Department of Primary Industries and Regions South Australia (PIRSA)
Industry
PROJECT NUMBER • 2019-106
PROJECT STATUS:
COMPLETED

Minor use permit for oxytetracycline in non-salmonid finfish

There are no registered or permitted antimicrobial products approved by the Australian Pesticide and Veterinary Medicine Authority (APVMA) for treatment of bacterial infections in finfish. This project developed an application for a minor-use permit (MUP) for the use of oxytetracycline (OTC) to...
ORGANISATION:
University of Adelaide
Industry
PROJECT NUMBER • 2016-117
PROJECT STATUS:
COMPLETED

NEAO: addressing current health issues confronting warm water culture of yellowtail kingfish

This project addressed a number of key issues associated with the culture of yellowtail kingfish (Seriola lalandi, YTK) in warm water, including optimising the use of hydrogen peroxide (which is more toxic in warm water), investigating alternatives to the management of monogenean flukes...
ORGANISATION:
Department of Primary Industries and Regional Development (DPIRD) Fremantle

Minor use permit for erythromycin in finfish

Project number: 2021-027
Project Status:
Current
Budget expenditure: $95,000.00
Principal Investigator: Marty R. Deveney
Organisation: University of Adelaide
Project start/end date: 21 Oct 2021 - 30 Jul 2022
Contact:
FRDC

Need

There are no antimicrobials permitted or registered for use in finfish in Australia effective against gram positive bacteria (e.g. Streptococcus and Lactococcus). In finfish aquaculture, erythromycin (ERYC) is the best antimicrobial against gram positive organisms. The aquaculture industry and the Subcommittee for Aquatic Animal Health identified access to this product for finfinfish as a priority. Bacterial diseases are increasingly managed by eradication, maintenance of animals of specified health status, vaccination, and good hygiene, but antimicrobial therapy remains vital for treating bacterial diseases in finfish aquaculture. Appropriate use of antimicrobials can alleviate illness and suffering, improve welfare, increase speed of recovery, reduce spread of infection. Use of ERYC is not intended for prophylactic treatment, but as a tool for veterinarians to manage disease outbreaks. Use in South Australia, for example, is sporadic (~1 to 2 times per 3-5 years for a sector). The Aquaculture industry is committed to Australia's antimicrobial strategy, and as required by APVMA this proposal includes an antimicrobial resistance risk assessment. Available data for ERYC can satisfy the APVMA module requirements for efficacy, chemistry and manufacture, toxicology, trade and occupational health and safety. These are available in published literature, a range of industry studies of animals treated off-label and laboratory studies. There is a lack of data to satisfy the requirements mainly in the environment modules and the antimicrobial resistance risk assessment.

ERYC was ranked low by the Expert Advisory Group on Antimicrobial Assessment (EAGAR) as an antimicrobial for which there are a reasonable number of alternative agents in different classes available to treat most infections. Although it is listed on the WHO list of essential medicines, it is registered for use in cattle, pigs and sheep (APVMA #84160) and poultry (APVMA #50742) in Australia and the WHO list can be modified locally to suit the availability and sophistication of the animal and human health systems in WHO member countries. The APVMA PAA assessed ERYC as suitable for assessment for use in finfish.

Objectives

1. Obtain data to satisfy identified gaps and collate available data to satisfy requirements of minor use permit application.
2. Collate and submit minor use permit application.
Industry
People
View Filter